Antibiotic Treatment for Cellulitis
For typical non-purulent cellulitis, first-line treatment should be an antibiotic active against streptococci, such as penicillin, amoxicillin, dicloxacillin, cephalexin, or clindamycin for a 5-day course. 1, 2
First-Line Therapy Based on Severity
Mild to Moderate Cellulitis
- First-line therapy should target beta-hemolytic streptococci with oral antibiotics such as penicillin, amoxicillin, dicloxacillin, or cephalexin for 5 days 1, 2
- For patients with penicillin allergy, clindamycin or erythromycin are recommended alternatives 1
- Levofloxacin can be considered for patients with beta-lactam allergies, with similar efficacy demonstrated in 5-day treatment courses 1, 3
Severe Cellulitis
- For severe cellulitis or high-risk patients, consider coverage for methicillin-resistant Staphylococcus aureus (MRSA) 1, 2
- Indications for MRSA coverage include:
- Treatment options for severe cellulitis include:
Combination Therapy Considerations
- If coverage for both beta-hemolytic streptococci and community-associated MRSA is desired, options include:
- Clindamycin alone
- Trimethoprim-sulfamethoxazole (TMP-SMX) in combination with a beta-lactam like amoxicillin
- A tetracycline in combination with a beta-lactam 1
- In areas with high MRSA prevalence, antibiotics with activity against MRSA (such as TMP-SMX or clindamycin) have shown higher success rates compared to cephalexin 4
Treatment Duration
- A 5-day course is sufficient for uncomplicated cellulitis, with extension if no improvement is seen 1, 2, 3
- For severe cellulitis, treatment duration may be extended to 7-14 days based on clinical response 1
Pathogen Considerations
- Cellulitis is primarily caused by beta-hemolytic streptococci, with Staphylococcus aureus less frequently involved unless associated with penetrating trauma or underlying abscess 1, 5
- Most non-purulent, uncomplicated cases of cellulitis are caused by beta-hemolytic streptococci or methicillin-sensitive S. aureus 5
- Even in areas with high rates of community-acquired MRSA, coverage for MRSA in non-purulent cellulitis is generally not recommended unless specific risk factors are present 1, 5
Adjunctive Measures
- Elevate the affected area to promote gravity drainage of edema and inflammatory substances 1, 2
- Treat predisposing conditions such as edema, tinea pedis, or other toe web abnormalities 1, 2
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients to hasten resolution 1, 2
Common Pitfalls to Avoid
- Failure to examine interdigital toe spaces for fissuring, scaling, or maceration that may harbor pathogens 1
- Not elevating the affected area, which delays improvement 1
- Inadequate treatment duration when clinical improvement is not evident after 5 days 1
- Unnecessary MRSA coverage for typical non-purulent cellulitis in the absence of specific risk factors 1, 5